TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials March 28, 1986
TCL Archive NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy October 26, 1984
TCL Archive Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program June 4, 1999
